Refrigeration optional
Starting the prior authorization process at least three weeks before you need your new medication helps prevent these gaps
As a once-monthly injectable therapy that does not require titration, it has the potential to simplify weight loss treatment, improve patient adherence, and achieve meaningful and durable outcomes
In this interview with Plastic Surgery Practice , Joely Kaufman, MD, a board-certified dermatologist, fellow of the American Academy of Dermatology, and director of Skin Associates of South Florida in Coral Gables, discusses findings from the study, Survey of Facial Aesthetic Concerns and Treatment Trends Following GLP-1 Agonist-Associated Weight Loss , presented at the 2025 American Society for Dermatologic Surgery Annual Meeting, and shares how plastic surgeons and other aesthetic providers are adapting their treatment algorithms to address the unique facial changes associated with GLP-1related weight loss
Avoid large, fatty meals on injection days
GLP-1 medications like semaglutide and tirzepatide are not approved by the FDA for patients under age 18, with limited pediatric trial data